What's New

The History


SyncThink upgrades hardware version 2.0 to Gear VR with built-in eye trackers.

SyncThink works with Shire to apply SyncThink technology to clinical models.


SyncThink awarded FDA clearance for EYE-SYNC, and its 10th patent.


Stanford adopts and develops protocol around EYE-SYNC.


SyncThink integrates eye tracking assessments onto emerging VR platform, called EYE-SYNC.



SyncThink is awarded Department of Defense grant to develop lightweight platform for field use.


SyncThink develops head-mounted eye tracking platform using clam shell design.

Brain Trauma Foundation awarded $25M grant to pursue largest-ever ocular-motor clinical study. 


First prototype headset developed.

Dr. Ghajar, Dr. Jun Maruta, and study link of predictive eye tracking impairment.



SyncThink founded to develop mobile eye tracking technology and analytics in support of research with Department of Defense.



In 2006, Dr. Jam Ghajar and Dr. Minah Suh publish an investigation into predictive eye tracking and mild traumatic brain injury (concussion) for Brain Trauma Foundation (BTF).

Two years later, Dr. Ghajar and Dr. Richard Ivry publish a new theory of Predictive Brain State – a mechanism for attention that is affected by injury.


First study of timing impairments funded by the James S. McDonnell Foundation, conducted in a collaboration between University of California, San Francisco, University of California, Berkeley, and Weill Cornell Medical College. The study was led by Dr. Jam Ghajar, Principal Investigator.

Blog: Behind an FDA Clearance

An FDA clearance is necessary to market a medical device in the United States. Everyone is aware that regulatory hurdles can be an expensive, intrusive process. Having one carries a lot of weight. However, few companies have been through the process and rarely discuss the challenges. But there are benefits to transparency. Users of SyncThink […]

Read article

Blog: Seeing What Can’t Be Seen:
A Firsthand Account of the Power of the SyncThink Platform

  When Opportunity Knocks When I was first exposed to the EYE-SYNC technology, I had already been working for five years as part of a collaborative, multidisciplinary group of researchers at Stanford to better understand the natural history of head injury. We maintained a collective curiosity about novel ways this epidemic could be better understood, […]

Read article

Blog: A Different Kind of Sync

I have had the good fortune to enjoy over 25 years of building a range of software businesses – enterprise and consumer – big companies and startups.   I loved the challenge and am proud of the positive impact of these products which have touched millions (SugarSync, Catch) and in some cases hundreds of millions (Netscape, […]

Read article

SyncThink Appoints Laura Yecies as Chief Executive Officer

SyncThink, a world leader in neurotechnology and brain health analytics with foundational IP in eye-tracking, announces the appointment of Laura Yecies as its new CEO.

Read article

Richard Sherman, Like More NFL Stars, Is Playing the Tech Game

By Jon Swartz March 16, 2018 4:03 p.m. ET Richard Sherman plays football for a living, but he’s also tackling the technology game. The four-time Pro Bowl cornerback, who recently signed a three-year, $39.15 million free-agent contract with the San Francisco 49ers, is one of a growing number of NFL stars helping promote tech start-ups. He’s an […]

Read article

The Top 6 Virtual Reality Digital Health Companies

Virtual reality in medicine is certainly a hot trend at the moment, with the global market for VR in healthcare expected to reach 3.8 billion by 2020. Justin Barad, Founder and CEO of startup Osso VR, summarizes the impact of immersive technology in medicine: “Virtual Reality is a unique technology that has a wide variety of disruptive medical […]

Read article

SyncThink reels in $3.5 mln

Palo Alto, CA—January 3, 2018—Sync-Think, Inc. (“SyncThink” and the “Company”) a world leader in neuro-technology and proprietary eye-tracking intellectual property, announces the closing of a Series A-1 Preferred Stock funding round consisting of $3.5 million dollars in cash subscriptions, led by Quadrant Management, Inc. The Company expects to utilize the proceeds from the offering to […]

Read article

12th VR Patent Granted To SyncThink

SyncThink was granted another huge patent that captures eye tracking attention and analyzes for a variety of purposes. SyncThink, a leader in neurotechnology and creator of EYE-SYNC, announces today the granting of patent US 14/530,598 by the U.S. Patent and Trade Office. This patent allows SyncThink to use system and methods for creating and changing […]

Read article

NFL Tight End, Coby Fleener, Joins SyncThink Athlete Advisory Board

A world leader in neuro-technology with foundational in IP in eye-tracking, SyncThink, adds New Orleans’ Saints Tight End, Coby Fleener, to its Athlete Advisory Board. In this advisory capacity, Fleener will contribute to the continued SyncThink mission of providing an objective solution with the SyncThink Platform. EYE-SYNC is designed with VR and eye-tracking technology to […]

Read article

Pulse@MassChallenge Spurs Deals in Digital Health Lab’s 1st Session


Read article

15 Entrepreneurs on What It’s Like to Be a Startup in Boston

Tech Cocktail

Read article

SyncThink Adds to Patents in Eye Tracking Devices and Analytics

SyncThink World Leader in Neuro-Technology Receives Patent for Eye Tracking in Virtual Reality Configuration SyncThink, one of the world leaders in neuro-technology with foundational intellectual property (IP) in eye tracking analytics and devices, announces today another patent granted from the U.S. Patent and Trade Office. US 9,439,592 grants SyncThink IP for adding eye tracking to common […]

Read article

Featured news